The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
Volume 344:1807-1814 June 14, 2001 Number 24
NextNext

The Outbreak of West Nile Virus Infection in the New York City Area in 1999
Denis Nash, Ph.D., M.P.H., Farzad Mostashari, M.D., M.S.P.H., Annie Fine, M.D., James Miller, M.D., M.P.H., Daniel O'Leary, D.V.M., Kristy Murray, D.V.M., Ada Huang, M.D., Amy Rosenberg, M.D., Abby Greenberg, M.D., Margaret Sherman, R.N., Susan Wong, Ph.D., Grant L. Campbell, M.D., Ph.D., John T. Roehrig, Ph.D., Duane J. Gubler, Sc.D., Wun-Ju Shieh, M.D., M.P.H., Ph.D., Sherif Zaki, M.D., Ph.D., Perry Smith, M.D., Marcelle Layton, M.D., for the 1999 West Nile Outbreak Response Working Group

 Sign up for free e-toc
 

This Article
-Full Text
- PDF

Commentary
-Editorial
 by Tyler, K. L.

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
ABSTRACT

Background In late August 1999, an unusual cluster of cases of meningoencephalitis associated with muscle weakness was reported to the New York City Department of Health. The initial epidemiologic and environmental investigations suggested an arboviral cause.

Methods Active surveillance was implemented to identify patients hospitalized with viral encephalitis and meningitis. Cerebrospinal fluid, serum, and tissue specimens from patients with suspected cases underwent serologic and viral testing for evidence of arboviral infection.

Results Outbreak surveillance identified 59 patients who were hospitalized with West Nile virus infection in the New York City area during August and September of 1999. The median age of these patients was 71 years (range, 5 to 90). The overall attack rate of clinical West Nile virus infection was at least 6.5 cases per million population, and it increased sharply with age. Most of the patients (63 percent) had clinical signs of encephalitis; seven patients died (12 percent). Muscle weakness was documented in 27 percent of the patients and flaccid paralysis in 10 percent; in all of the latter, nerve conduction studies indicated an axonal polyneuropathy. An age of 75 years or older was an independent risk factor for death (relative risk adjusted for the presence or absence of diabetes mellitus, 8.5; 95 percent confidence interval, 1.2 to 59.1), as was the presence of diabetes mellitus (age-adjusted relative risk, 5.1; 95 percent confidence interval, 1.5 to 17.3).

Conclusions This outbreak of West Nile meningoencephalitis in the New York City metropolitan area represents the first time this virus has been detected in the Western Hemisphere. Given the subsequent rapid spread of the virus, physicians along the eastern seaboard of the United States should consider West Nile virus infection in the differential diagnosis of encephalitis and viral meningitis during the summer months, especially in older patients and in those with muscle weakness.


Source Information

From the Communicable Disease Program, New York City Department of Health, New York (D.N., F.M., A.F., J.M., M.L.); the Epidemic Intelligence Service, Epidemiology Program Office, Division of Applied Public Health Training, State Branch (D.N., F.M.), and the Division of Bioterrorism Preparedness (K.M.), Centers for Disease Control and Prevention, Atlanta; the Division of Vector-Borne Infectious Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colo. (D.O.); the Westchester County Department of Health, New Rochelle, N.Y. (A.H., A.R.); the Nassau County Department of Health, Mineola, N.Y. (A.G., M.S.); and the New York State Department of Health, Albany (S.W.).

Other authors were Grant L. Campbell, M.D., Ph.D., John T. Roehrig, Ph.D., and Duane J. Gubler, Sc.D. (Centers for Disease Control and Prevention, Fort Collins, Colo.); Wun-Ju Shieh, M.D., M.P.H., Ph.D., and Sherif Zaki, M.D., Ph.D. (Centers for Disease Control and Prevention, Atlanta); and Perry Smith, M.D. (New York State Department of Health, Albany).

Address reprint requests to Dr. Nash at the New York City Department of Health, HIV/AIDS Surveillance Program, 346 Broadway, Rm. 706, New York, NY 10013, or at dnash{at}health.nyc.gov.

Full Text of this Article


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.